Log In
Print this Print this

Intuniv, guanfacine extended release (S-877503)

Also known as: GXR, guanfacine hydrochloride (formerly Connexyn, SPD503)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAdrenergic receptor alpha 2a (ADRA2A) agonist
Molecular Target Adrenergic receptor alpha 2a (ADRA2A)
Mechanism of ActionAdrenoceptor alpha 2a agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD; Treat ADHD in adolescents age 6-17; Treat ADHD in children who exhibit oppositional behavior
Regulatory Designation EU - Standard Review (Treat ADHD in adolescents age 6-17)
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today